四天三笔跨国药企交易，潜在最高总额超过180亿美元。 2026年10月2日，诺华与中国生物科技公司艾博生物达成推进RNA疗法的授权及许可选择权协议，获得ABO2203管线（mRNA编码CD19xCD3 ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310 ®, its ...

Researchers have used CRISPR-Cas9 to remove CD28 from donor T cells and prevent fratricide before equipping them with ...

CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and ...

CRISPR-generated knockout mutants reveal that the highly expressed, symbiosome-localized nodulin NOD25 is dispensable for ...

Most of any gains (or lack thereof) from here will be driven by just three factors.

A new commentary in Discover Plants argues that genomics, CRISPR genome editing, and tissue culture must be integrated with ...

In CRISPR gene editing, guide RNA (gRNA) directs the Cas9 complex to its target. Impurities introduced during gRNA synthesis ...

ZUG, Switzerland, BOSTON - CRISPR Therapeutics (Nasdaq: CRSP), announced that a poster presentation highlighting the Company's Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited ...

Gene-edited banana by Tropic Biosciences clears England's first regulatory hurdle, showing 30% less browning, but FSA ...

CRISPR Therapeutics AG Reports Q2 Revenue $10.2M, vs. FactSet Est of $7.4M MT Aug. 03 CRISPR Therapeutics AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI Jun.

Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...